Alcoholic liver disease patients treated with S-adenosyl-l-methionine: An in-depth look at liver morphologic data comparing pre and post treatment liver biopsies

Mary D. Le, Elena Enbom, Peter K. Traum, Valentina Medici, Charles H. Halsted, Samuel W. French

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: The objective of this study is to assess if there were any changes in liver biopsies after treatment with S-adenosyl-. l-methionine(SAMe) in alcoholic liver disease patients. Methods: Liver biopsies of 14 patients were randomized for SAMe treatment at week 0 (biopsy #1) and at 24. weeks (biopsy #2). Patients received 1.2. g of SAMe or placebo by mouth daily and stopped alcohol intake. Biopsies were semi-quantitatively scored for: steatosis, inflammation, necrosis, fibrosis, apoptosis by TUNEL stain, percent fibrosis per square field, smooth muscle actin stain, Kupffer cells, polymorphonuclear leukocytes, lipogranules, lymphocytes, balloon cell formation, Mallory-Denk bodies, and duct metaplasia. Results: Comparing treatment arm to placebo arm, no significant difference was found between biopsy #1 and biopsy #2. However, when both study arms were grouped together, there was decrease in smooth muscle actin stain, where the P-value. =. 0.027. Conclusion: Treatment with SAMe did not show a statistically significant difference in the characteristics studied. However, when both the treatment and placebo arm data were grouped together to increase the n and power, there was a decrease in the smooth muscle actin stain, reflecting a decrease in stellate cells activation, likely due to the alcohol abstinence. This study suggests that it may not be beneficial to wait for more definitive treatment, like liver transplant in alcoholic liver disease patients, since the liver tissue remained largely with the same degree of pathology six months out, regardless of treatment.

Original languageEnglish (US)
Pages (from-to)187-191
Number of pages5
JournalExperimental and Molecular Pathology
Volume95
Issue number2
DOIs
StatePublished - Oct 2013

Fingerprint

Alcoholic Liver Diseases
Biopsy
Methionine
Liver
Arm
Coloring Agents
Smooth Muscle
Muscle
Actins
Placebos
Therapeutics
Fibrosis
Mallory Bodies
Alcohols
Alcohol Abstinence
Transplants
Kupffer Cells
Lymphocytes
Balloons
In Situ Nick-End Labeling

Keywords

  • Alcoholic liver disease
  • Liver biopsies
  • S-adenosyl-l-methionine
  • Smooth muscle actin

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Alcoholic liver disease patients treated with S-adenosyl-l-methionine : An in-depth look at liver morphologic data comparing pre and post treatment liver biopsies. / Le, Mary D.; Enbom, Elena; Traum, Peter K.; Medici, Valentina; Halsted, Charles H.; French, Samuel W.

In: Experimental and Molecular Pathology, Vol. 95, No. 2, 10.2013, p. 187-191.

Research output: Contribution to journalArticle

@article{95ed80b639cf4cf499e213df2d83e97a,
title = "Alcoholic liver disease patients treated with S-adenosyl-l-methionine: An in-depth look at liver morphologic data comparing pre and post treatment liver biopsies",
abstract = "Background: The objective of this study is to assess if there were any changes in liver biopsies after treatment with S-adenosyl-. l-methionine(SAMe) in alcoholic liver disease patients. Methods: Liver biopsies of 14 patients were randomized for SAMe treatment at week 0 (biopsy #1) and at 24. weeks (biopsy #2). Patients received 1.2. g of SAMe or placebo by mouth daily and stopped alcohol intake. Biopsies were semi-quantitatively scored for: steatosis, inflammation, necrosis, fibrosis, apoptosis by TUNEL stain, percent fibrosis per square field, smooth muscle actin stain, Kupffer cells, polymorphonuclear leukocytes, lipogranules, lymphocytes, balloon cell formation, Mallory-Denk bodies, and duct metaplasia. Results: Comparing treatment arm to placebo arm, no significant difference was found between biopsy #1 and biopsy #2. However, when both study arms were grouped together, there was decrease in smooth muscle actin stain, where the P-value. =. 0.027. Conclusion: Treatment with SAMe did not show a statistically significant difference in the characteristics studied. However, when both the treatment and placebo arm data were grouped together to increase the n and power, there was a decrease in the smooth muscle actin stain, reflecting a decrease in stellate cells activation, likely due to the alcohol abstinence. This study suggests that it may not be beneficial to wait for more definitive treatment, like liver transplant in alcoholic liver disease patients, since the liver tissue remained largely with the same degree of pathology six months out, regardless of treatment.",
keywords = "Alcoholic liver disease, Liver biopsies, S-adenosyl-l-methionine, Smooth muscle actin",
author = "Le, {Mary D.} and Elena Enbom and Traum, {Peter K.} and Valentina Medici and Halsted, {Charles H.} and French, {Samuel W.}",
year = "2013",
month = "10",
doi = "10.1016/j.yexmp.2013.07.003",
language = "English (US)",
volume = "95",
pages = "187--191",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Alcoholic liver disease patients treated with S-adenosyl-l-methionine

T2 - An in-depth look at liver morphologic data comparing pre and post treatment liver biopsies

AU - Le, Mary D.

AU - Enbom, Elena

AU - Traum, Peter K.

AU - Medici, Valentina

AU - Halsted, Charles H.

AU - French, Samuel W.

PY - 2013/10

Y1 - 2013/10

N2 - Background: The objective of this study is to assess if there were any changes in liver biopsies after treatment with S-adenosyl-. l-methionine(SAMe) in alcoholic liver disease patients. Methods: Liver biopsies of 14 patients were randomized for SAMe treatment at week 0 (biopsy #1) and at 24. weeks (biopsy #2). Patients received 1.2. g of SAMe or placebo by mouth daily and stopped alcohol intake. Biopsies were semi-quantitatively scored for: steatosis, inflammation, necrosis, fibrosis, apoptosis by TUNEL stain, percent fibrosis per square field, smooth muscle actin stain, Kupffer cells, polymorphonuclear leukocytes, lipogranules, lymphocytes, balloon cell formation, Mallory-Denk bodies, and duct metaplasia. Results: Comparing treatment arm to placebo arm, no significant difference was found between biopsy #1 and biopsy #2. However, when both study arms were grouped together, there was decrease in smooth muscle actin stain, where the P-value. =. 0.027. Conclusion: Treatment with SAMe did not show a statistically significant difference in the characteristics studied. However, when both the treatment and placebo arm data were grouped together to increase the n and power, there was a decrease in the smooth muscle actin stain, reflecting a decrease in stellate cells activation, likely due to the alcohol abstinence. This study suggests that it may not be beneficial to wait for more definitive treatment, like liver transplant in alcoholic liver disease patients, since the liver tissue remained largely with the same degree of pathology six months out, regardless of treatment.

AB - Background: The objective of this study is to assess if there were any changes in liver biopsies after treatment with S-adenosyl-. l-methionine(SAMe) in alcoholic liver disease patients. Methods: Liver biopsies of 14 patients were randomized for SAMe treatment at week 0 (biopsy #1) and at 24. weeks (biopsy #2). Patients received 1.2. g of SAMe or placebo by mouth daily and stopped alcohol intake. Biopsies were semi-quantitatively scored for: steatosis, inflammation, necrosis, fibrosis, apoptosis by TUNEL stain, percent fibrosis per square field, smooth muscle actin stain, Kupffer cells, polymorphonuclear leukocytes, lipogranules, lymphocytes, balloon cell formation, Mallory-Denk bodies, and duct metaplasia. Results: Comparing treatment arm to placebo arm, no significant difference was found between biopsy #1 and biopsy #2. However, when both study arms were grouped together, there was decrease in smooth muscle actin stain, where the P-value. =. 0.027. Conclusion: Treatment with SAMe did not show a statistically significant difference in the characteristics studied. However, when both the treatment and placebo arm data were grouped together to increase the n and power, there was a decrease in the smooth muscle actin stain, reflecting a decrease in stellate cells activation, likely due to the alcohol abstinence. This study suggests that it may not be beneficial to wait for more definitive treatment, like liver transplant in alcoholic liver disease patients, since the liver tissue remained largely with the same degree of pathology six months out, regardless of treatment.

KW - Alcoholic liver disease

KW - Liver biopsies

KW - S-adenosyl-l-methionine

KW - Smooth muscle actin

UR - http://www.scopus.com/inward/record.url?scp=84882807358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882807358&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2013.07.003

DO - 10.1016/j.yexmp.2013.07.003

M3 - Article

C2 - 23886644

AN - SCOPUS:84882807358

VL - 95

SP - 187

EP - 191

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 2

ER -